A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III clinical trial to assess the efficacy and safety of Yuping Tongqiao tablets in the treatment of persistent allergic rhinitis.
Wang M, Wang J, Chen J, Deng C, Dong Y, Yang X, Wang N, Li X, Liu W, Lu B, Cheng X, Yu B, Zhu Z, Wang R, Dong H, Chen X, Li X, Jiang L, He J, Huang C, Liu W, Song X, Li G, Ye J, Wang G, Yan Z, Liang G, Jiang Q, Yang Y, Peng L, Tang J, Liu Z, Cheng J, Han J, Sun L.
Wang M, et al. Among authors: wang n.
J Ethnopharmacol. 2025 Jul 24;351:120091. doi: 10.1016/j.jep.2025.120091. Epub 2025 Jun 3.
J Ethnopharmacol. 2025.
PMID: 40473149
Free article.
Clinical Trial.